A431 Cells

The A431 cell line, derived from a solid epidermoid carcinoma tumor in an 85-year-old female patient, is a human tumor cell line with an epithelial morphology, typically growing in clusters. The A-431 cell line is extensively utilized in cancer, toxicity, and immuno-oncology studies, serving as a positive control for epidermal growth factor (EGF) receptor expression due to its high receptor density. Upon binding of EGF to its receptor (EGFR) on the surface of A431 cells, a rapid tyrosine phosphorylation of membrane proteins occurs, triggering a cascade of intracellular signaling pathways. These pathways include the MAPK/ERK and PI3K/AKT pathways, which are pivotal in regulating cell cycle progression, survival, and proliferation. EGFR stimulates cell proliferation at low concentrations, whereas at higher concentrations, it inhibits growth and induces terminal differentiation in A431 cells. This dynamic response to EGFR underscores the cell line's utility in exploring cell signaling pathways and the cell cycle in the context of cancer. A-431 cell-derived xenograft models are used for studying tumor behavior in a live environment and evaluating anticancer therapies. These models help assess how treatments such as EGF supplementation and radiation, affect tumor growth and highlight the cells' sensitivity to radiation. In summary, the A-431 cell line serves as an invaluable human epidermoid carcinoma cell model, facilitating a deeper understanding of EGFR signaling, tumor biology, and the development of therapeutic interventions aimed at combating epidermoid carcinoma and other related cancers.